Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Beliefs about antidepressants among persons aged 70 years and older in treatment after a suicide attempt.

Lesén E, Wiktorsson S, Carlsten A, Waern M, Hedenrud T.

Int Psychogeriatr. 2015 Nov;27(11):1795-803. doi: 10.1017/S1041610215000216. Epub 2015 Mar 2.

PMID:
25727814
2.

Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults.

Gyllensten H, Hakkarainen KM, Hägg S, Carlsten A, Petzold M, Rehnberg C, Jönsson AK.

PLoS One. 2014 Mar 17;9(3):e92061. doi: 10.1371/journal.pone.0092061. eCollection 2014.

3.

Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey.

Gyllensten H, Rehnberg C, Jönsson AK, Petzold M, Carlsten A, Andersson Sundell K.

BMJ Open. 2013 Jun 20;3(6). pii: e002574. doi: 10.1136/bmjopen-2013-002574.

4.

Is the level of patient co-payment for medicines associated with refill adherence in Sweden?

Lesén E, Andersson Sundell K, Carlsten A, Mårdby AC, Jönsson AK.

Eur J Public Health. 2014 Feb;24(1):85-90. doi: 10.1093/eurpub/ckt062. Epub 2013 Jun 6.

5.

Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.

Vilhelmsson A, Svensson T, Meeuwisse A, Carlsten A.

BMC Pharmacol Toxicol. 2012 Dec 23;13:19. doi: 10.1186/2050-6511-13-19.

6.

Modelling drug-related morbidity in Sweden using an expert panel of pharmacists'.

Gyllensten H, Hakkarainen KM, Jönsson AK, Andersson Sundell K, Hägg S, Rehnberg C, Carlsten A.

Int J Clin Pharm. 2012 Aug;34(4):538-46. doi: 10.1007/s11096-012-9641-3. Epub 2012 Apr 28.

PMID:
22544221
7.

Modelling drug-related morbidity in Sweden using an expert panel of physicians.

Hakkarainen KM, Alström D, Hägg S, Carlsten A, Gyllensten H.

Eur J Clin Pharmacol. 2012 Sep;68(9):1309-19. doi: 10.1007/s00228-012-1244-3. Epub 2012 Mar 6.

PMID:
22392557
8.

How are the costs of drug-related morbidity measured?: a systematic literature review.

Gyllensten H, Jönsson AK, Rehnberg C, Carlsten A.

Drug Saf. 2012 Mar 1;35(3):207-19. doi: 10.2165/11597090-000000000-00000. Review.

PMID:
22242773
9.

What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.

Vilhelmsson A, Svensson T, Meeuwisse A, Carlsten A.

BMC Clin Pharmacol. 2011 Oct 25;11:16. doi: 10.1186/1472-6904-11-16.

10.

A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project.

Lesén E, Sandström TZ, Carlsten A, Jönsson AK, Mårdby AC, Sundell KA.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1073-9. doi: 10.1002/pds.2204. Epub 2011 Aug 19.

PMID:
21853505
11.

Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study.

Lesén E, Carlsten A, Skoog I, Waern M, Petzold M, Börjesson-Hanson A.

Int Psychogeriatr. 2011 Oct;23(8):1270-7. doi: 10.1017/S1041610211000524. Epub 2011 Mar 28.

PMID:
21447258
12.

There is a trend in the utilization of psychotropics among elderly towards recommended drugs.

Lesén E, Carlsten A.

Pharmacoepidemiol Drug Saf. 2010 Oct;19(10):1095-9. doi: 10.1002/pds.1967.

PMID:
20712025
13.

Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis.

Olsson J, Bergman A, Carlsten A, Oké T, Bernsten C, Schmidt IK, Fastbom J.

Clin Drug Investig. 2010;30(5):289-300. doi: 10.2165/11534320-000000000-00000.

PMID:
20384385
14.

Socioeconomic determinants of psychotropic drug utilisation among elderly: a national population-based cross-sectional study.

Lesén E, Andersson K, Petzold M, Carlsten A.

BMC Public Health. 2010 Mar 9;10:118. doi: 10.1186/1471-2458-10-118.

15.

Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly?

Carlsten A, Waern M.

BMC Geriatr. 2009 Jun 4;9:20. doi: 10.1186/1471-2318-9-20.

16.

Prescribing behaviour after the introduction of decentralized drug budgets: is there an association with employer and type of care facility?

Andersson K, Carlsten A, Hedenrud T.

Scand J Prim Health Care. 2009;27(2):117-22. doi: 10.1080/02813430902793225.

17.

To what extent does the indicator "concurrent use of three or more psychotropic drugs" capture use of potentially inappropriate psychotropics among the elderly?

Lesén E, Petzold M, Andersson K, Carlsten A.

Eur J Clin Pharmacol. 2009 Jun;65(6):635-42. doi: 10.1007/s00228-009-0623-x. Epub 2009 Feb 12.

PMID:
19219427
18.

Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.

Andersson KA, Petzold MG, Allebeck P, Carlsten A.

BMC Health Serv Res. 2008 Feb 29;8:50. doi: 10.1186/1472-6963-8-50.

19.

Evaluation of the quality of drug therapy among elderly patients in nursing homes.

Bergman A, Olsson J, Carlsten A, Waern M, Fastbom J.

Scand J Prim Health Care. 2007 Mar;25(1):9-14.

20.

Can selective serotonin inhibitor drugs in elderly patients in nursing homes be reduced?

Lindström K, Ekedahl A, Carlsten A, Mårtensson J, Mölstad S.

Scand J Prim Health Care. 2007 Mar;25(1):3-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk